Last reviewed · How we verify

eurartesim film coated tablet

sigma-tau i.f.r. S.p.A. · Phase 2 active Small molecule

eurartesim film coated tablet is a Small molecule drug developed by sigma-tau i.f.r. S.p.A.. It is currently in Phase 2 development. Also known as: Piperaquine tetraphosphate plus dihydroartemisinin.

At a glance

Generic nameeurartesim film coated tablet
Also known asPiperaquine tetraphosphate plus dihydroartemisinin
Sponsorsigma-tau i.f.r. S.p.A.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about eurartesim film coated tablet

What is eurartesim film coated tablet?

eurartesim film coated tablet is a Small molecule drug developed by sigma-tau i.f.r. S.p.A..

Who makes eurartesim film coated tablet?

eurartesim film coated tablet is developed by sigma-tau i.f.r. S.p.A. (see full sigma-tau i.f.r. S.p.A. pipeline at /company/sigma-tau-i-f-r-s-p-a).

Is eurartesim film coated tablet also known as anything else?

eurartesim film coated tablet is also known as Piperaquine tetraphosphate plus dihydroartemisinin.

What development phase is eurartesim film coated tablet in?

eurartesim film coated tablet is in Phase 2.

Related